Pictet Asset Management (Switzerland)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $43.6M | Buy |
2,532,716
+1,090,284
| +76% | +$18.8M | 0.05% | 315 |
|
|
2023
Q1 | $23.9M | Buy |
1,442,432
+901,628
| +167% | +$14.9M | 0.03% | 422 |
|
|
2022
Q4 | $4.12M | Buy |
540,804
+142,039
| +36% | +$1.08M | 0.01% | 777 |
|
|
2022
Q3 | $3.96M | Buy |
398,765
+110,107
| +38% | +$1.09M | 0.01% | 780 |
|
|
2022
Q2 | $2.62M | Buy |
288,658
+196,988
| +215% | +$1.79M | ﹤0.01% | 888 |
|
|
2022
Q1 | $930K | Hold |
91,670
| – | – | ﹤0.01% | 1058 |
|
|
2021
Q4 | $1.53M | Buy |
91,670
+22,599
| +33% | +$377K | ﹤0.01% | 1017 |
|
|
2021
Q3 | $3.24M | Buy |
+69,071
| New | +$3.24M | ﹤0.01% | 919 |
|